Comments

Scholar Rock Holding Stock Price, Quotes and Forecasts

Q: What sector and industry does Scholar Rock Holding (SRRK) operate in?

Scholar Rock Holding is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SRRKNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$35.48

-0.33-0.92%

At close: -

$35.85

0.371.04%

After Hours: 4:45 PM EDT

Scholar Rock Holding (SRRK) Forecast

News Earnings Scholar Rock Holding (SRRK) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Scholar Rock Holding Stock Price, Quotes and Forecasts | NASDAQ:SRRK | Benzinga

Explore Scholar Rock Holding stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SRRK.

Open	$36.09
Close	$35.48
Volume / Avg.	848.88K / 1.37M
Day Range	$34.72 - $36.20
52 Wk Range	6.76 - 46.98
Market Cap	$3.40B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	27.81%
Days to Cover	14.09

Recent News

Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study

Scholar Rock's apitegromab helped preserve muscle mass during tirzepatide-induced weight loss, improving overall body composition in Phase 2 trial.

Vandana Singh

Greif Posts Upbeat Earnings, Joins Planet Labs PBC, IperionX, Owens & Minor And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment

Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy and safety in SMA treatment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$36.09
Close	$35.48
Volume / Avg.	848.88K / 1.37M
Day Range	$34.72 - $36.20
52 Wk Range	6.76 - 46.98
Market Cap	$3.40B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	27.81%
Days to Cover	14.09

About Scholar Rock Holding Corp

Sector

Health Care

Industry

Biotechnology

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Scholar Rock Holding (SRRK) stock?

You can purchase shares of Scholar Rock Holding (NASDAQ:SRRK) through any online brokerage.

View our list of the best stock brokerages

Who are Scholar Rock Holding (SRRK) competitors?

Other companies in Scholar Rock Holding’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ascentage Pharma Group (NASDAQ:AAPG).

What is the forecast, or price target, for Scholar Rock Holding (SRRK) stock?

Scholar Rock Holding has a consensus price target of $37.22.

What is the current price for Scholar Rock Holding (SRRK)?

The stock price for Scholar Rock Holding (NASDAQ: SRRK) is $35.8501 last updated June 26, 2025 at 4:45 PM EDT.

Does Scholar Rock Holding (SRRK) pay a dividend?

There are no upcoming dividends for Scholar Rock Holding.

When is Scholar Rock Holding (NASDAQ:SRRK) reporting earnings?

Scholar Rock Holding’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Scholar Rock Holding (SRRK) going to split?

There is no upcoming split for Scholar Rock Holding.

What sector and industry does Scholar Rock Holding (SRRK) operate in?

Scholar Rock Holding is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.